<!DOCTYPE html>
<html lang="en">

<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 6: Supporting Clients with Substance Use Disorders</title>
 <style>
 /* Base & Reset */
 * {
 box-sizing: border-box;
 }

 body {
 font-family: Georgia, 'Times New Roman', serif;
 line-height: 1.8;
 color: #2d2d2d;
 background: #f8f6f3;
 margin: 0;
 padding: 0;
 }

 /* Main Container */
 .lesson-container {
 max-width: 860px;
 margin: 0 auto;
 padding: 40px 30px;
 background: #ffffff;
 min-height: 100vh;
 box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
 }

 /* Module Header */
 .module-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 35px 35px 30px;
 border-radius: 16px;
 margin-bottom: 30px;
 position: relative;
 overflow: hidden;
 }

 .module-header::before {
 content: '';
 position: absolute;
 top: 0;
 right: 0;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
 transform: translate(100px, -100px);
 }

 .module-header::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 100%;
 height: 4px;
 background: #B8860B;
 }

 .module-label {
 margin: 0;
 font-size: 11px;
 color: rgba(255, 255, 255, 0.75);
 text-transform: uppercase;
 letter-spacing: 2.5px;
 font-weight: 500;
 }

 .lesson-title {
 margin: 10px 0 0 0;
 font-size: 28px;
 color: #ffffff;
 font-weight: 700;
 line-height: 1.3;
 position: relative;
 }

 .lesson-meta {
 display: flex;
 gap: 12px;
 margin-top: 20px;
 padding-top: 18px;
 border-top: 1px solid rgba(255, 255, 255, 0.15);
 flex-wrap: wrap;
 }

 .meta-item {
 display: flex;
 align-items: center;
 gap: 6px;
 font-size: 12px;
 color: rgba(255, 255, 255, 0.85);
 background: rgba(255, 255, 255, 0.1);
 padding: 5px 12px;
 border-radius: 4px;
 }

 /* Table of Contents */
 .toc-box {
 background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
 border-radius: 14px;
 padding: 24px 28px;
 margin-bottom: 35px;
 border: 1px solid #e8e8e8;
 }

 .toc-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 padding-bottom: 12px;
 border-bottom: 1px solid #e0e0e0;
 }

 .toc-list {
 list-style: none;
 margin: 0;
 padding: 0;
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 8px 24px;
 }

 .toc-list li {
 margin: 0;
 }

 .toc-list a {
 display: flex;
 align-items: center;
 padding: 8px 12px;
 color: #555;
 text-decoration: none;
 font-size: 14px;
 border-radius: 6px;
 transition: all 0.2s ease;
 }

 .toc-list a:hover {
 background: white;
 color: #047857;
 box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
 }

 .toc-list .section-num {
 display: inline-flex;
 align-items: center;
 justify-content: center;
 width: 26px;
 height: 26px;
 background: #047857;
 color: white;
 font-weight: 600;
 font-size: 11px;
 border-radius: 6px;
 margin-right: 12px;
 flex-shrink: 0;
 }

 @media (max-width: 600px) {
 .toc-list {
 grid-template-columns: 1fr;
 }
 }

 /* Learning Objectives */
 .objectives-box {
 background: #ecfdf5;
 border: 2px solid #047857;
 border-radius: 14px;
 padding: 30px 35px;
 margin-bottom: 40px;
 }

 .objectives-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 display: flex;
 align-items: center;
 gap: 10px;
 }

 .objectives-box .box-label::before {
 content: 'ðŸŽ¯';
 font-size: 18px;
 }

 .objectives-box ul {
 margin: 0;
 padding-left: 22px;
 }

 .objectives-box li {
 margin-bottom: 14px;
 font-size: 16px;
 line-height: 1.7;
 }

 .objectives-box li:last-child {
 margin-bottom: 0;
 }

 /* Key Terms Box */
 .key-terms-box {
 background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
 border-radius: 14px;
 padding: 28px 30px;
 margin: 40px 0;
 border: 1px solid #d8dce0;
 }

 .key-terms-box .box-label {
 font-weight: 600;
 color: #047857;
 margin: 0 0 18px 0;
 font-size: 13px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .terms-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 }

 .term-item {
 background: white;
 padding: 16px 18px;
 border-radius: 10px;
 border-left: 4px solid #059669;
 }

 .term-item .term {
 font-weight: 700;
 color: #059669;
 font-size: 15px;
 margin: 0 0 6px 0;
 }

 .term-item .definition {
 font-size: 14px;
 color: #555;
 margin: 0;
 line-height: 1.6;
 }

 /* Section Headings */
 h2 {
 font-size: 24px;
 color: #047857;
 margin: 50px 0 20px 0;
 font-weight: 600;
 position: relative;
 padding-bottom: 12px;
 }

 h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 3px;
 background: #B8860B;
 }

 /* Paragraphs */
 p {
 font-size: 17px;
 margin-bottom: 20px;
 color: #333;
 }

 /* Highlights */
 .highlight {
 color: inherit;
 background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
 padding: 0 4px;
 font-weight: 500;
 }

 /* Welcome/Intro Box */
 .welcome-box {
 background: linear-gradient(135deg, #f0fdf4 0%, #ecfdf5 100%);
 padding: 30px 35px;
 border-radius: 14px;
 margin-bottom: 40px;
 border: 1px solid #bbf7d0;
 }

 .welcome-box h3 {
 margin: 0 0 15px 0;
 font-size: 20px;
 color: #047857;
 font-weight: 600;
 }

 .welcome-box p {
 margin: 0;
 font-size: 17px;
 line-height: 1.8;
 color: #444;
 }

 /* Alert Boxes */
 .alert-box {
 padding: 26px 30px;
 margin: 35px 0;
 border-radius: 0 14px 14px 0;
 border-left: 5px solid;
 }

 .alert-box .alert-label {
 font-weight: 600;
 margin: 0 0 12px 0;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 2px;
 }

 .alert-box p:last-child {
 margin: 0;
 font-size: 16px;
 line-height: 1.7;
 }

 .alert-box.warning {
 background: #fff8e6;
 border-left-color: #ff9800;
 }

 .alert-box.warning .alert-label {
 color: #e65100;
 }

 .alert-box.success {
 background: #f0f8f0;
 border-left-color: #4caf50;
 }

 .alert-box.success .alert-label {
 color: #2e7d32;
 }

 .alert-box.reflect {
 background: #f8f0fa;
 border-left-color: #9c27b0;
 }

 .alert-box.reflect .alert-label {
 color: #7b1fa2;
 }

 .alert-box.info {
 background: #e3f2fd;
 border-left-color: #2196f3;
 }

 .alert-box.info .alert-label {
 color: #1565c0;
 }

 /* Case Study Box */
 .case-study {
 background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
 border-radius: 16px;
 padding: 0;
 margin: 40px 0;
 overflow: hidden;
 box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
 border-left: 5px solid #047857;
 }

 .case-study-header {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 20px 30px;
 display: flex;
 align-items: center;
 gap: 15px;
 }

 .case-study-icon {
 width: 45px;
 height: 45px;
 background: rgba(255, 255, 255, 0.15);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 }

 .case-study-header .box-label {
 font-weight: 600;
 color: #ffffff;
 margin: 0;
 font-size: 16px;
 letter-spacing: 0.5px;
 }

 .case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 13px;
 margin: 4px 0 0 0;
 }

 .case-study-content {
 padding: 28px 30px;
 }

 .case-study-content p {
 font-size: 16px;
 margin-bottom: 18px;
 }

 .case-study-content ul {
 margin: 18px 0;
 padding-left: 22px;
 }

 .case-study-content li {
 margin-bottom: 10px;
 font-size: 15px;
 }

 .patient-profile {
 display: flex;
 align-items: center;
 gap: 18px;
 padding: 18px 22px;
 background: white;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e5e5;
 }

 .patient-avatar {
 width: 55px;
 height: 55px;
 background: linear-gradient(135deg, #10B981, #059669);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 flex-shrink: 0;
 }

 .patient-info h4 {
 margin: 0 0 5px 0;
 font-size: 17px;
 color: #1a1a1a;
 }

 .patient-info p {
 margin: 0;
 font-size: 14px;
 color: #666;
 }

 /* Comparison Cards */
 .comparison-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 20px;
 margin: 30px 0;
 }

 .comparison-card {
 border-radius: 14px;
 padding: 26px;
 border-top: 5px solid;
 transition: transform 0.2s ease;
 }

 .comparison-card:hover {
 transform: translateY(-3px);
 }

 .comparison-card.conventional {
 background: #fff5f5;
 border-top-color: #c62828;
 }

 .comparison-card.functional {
 background: #f1f8f1;
 border-top-color: #2e7d32;
 }

 .comparison-card .card-label {
 font-weight: 600;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 margin: 0 0 14px 0;
 }

 .comparison-card.conventional .card-label {
 color: #c62828;
 }

 .comparison-card.functional .card-label {
 color: #2e7d32;
 }

 .comparison-card .card-text {
 margin: 0;
 font-size: 16px;
 font-style: italic;
 line-height: 1.6;
 }

 /* Content Lists */
 .content-list {
 font-size: 17px;
 margin: 20px 0;
 padding-left: 24px;
 }

 .content-list li {
 margin-bottom: 14px;
 line-height: 1.7;
 }

 .content-list li:last-child {
 margin-bottom: 0;
 }

 /* Statistics Box */
 .stats-box {
 background: linear-gradient(135deg, #047857 0%, #059669 100%);
 padding: 40px;
 border-radius: 16px;
 margin: 35px 0;
 position: relative;
 overflow: hidden;
 }

 .stats-box::before {
 content: '';
 position: absolute;
 top: -50%;
 right: -20%;
 width: 300px;
 height: 300px;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.08) 0%, transparent 70%);
 }

 .stats-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
 gap: 25px;
 position: relative;
 }

 .stat-item {
 text-align: center;
 }

 .stat-number {
 font-size: 42px;
 font-weight: 700;
 color: white;
 line-height: 1;
 margin-bottom: 8px;
 }

 .stat-label {
 font-size: 13px;
 color: rgba(255, 255, 255, 0.85);
 text-transform: uppercase;
 letter-spacing: 1px;
 }

 /* Principle Cards */
 .principle-card {
 background: linear-gradient(to right, #fafafa, #ffffff);
 border-left: 5px solid #047857;
 padding: 24px 28px;
 margin-bottom: 18px;
 border-radius: 0 14px 14px 0;
 box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
 transition: transform 0.2s ease, box-shadow 0.2s ease;
 }

 .principle-card:hover {
 transform: translateX(5px);
 box-shadow: 0 4px 18px rgba(0, 0, 0, 0.08);
 }

 .principle-card .principle-title {
 font-weight: 700;
 color: #047857;
 margin: 0 0 10px 0;
 font-size: 17px;
 }

 .principle-card .principle-text {
 margin: 0;
 font-size: 15px;
 line-height: 1.7;
 }

 .principle-card ul {
 margin: 12px 0 0 0;
 padding-left: 20px;
 font-size: 14px;
 }

 .principle-card li {
 margin-bottom: 5px;
 }

 /* Check Understanding Box */
 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }

 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }

 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }

 .reveal-btn {
 background: #047857;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }

 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #f0fdf4;
 border-radius: 8px;
 color: #166534;
 font-size: 16px;
 border-left: 4px solid #22c55e;
 }

 .answer-text.show {
 display: block;
 }

 /* Key Takeaways */
 .takeaways-box {
 background: #047857;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }

 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }

 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 }

 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 /* Interactive Diagram */
 .interactive-diagram {
 background: white;
 border: 2px solid #e5e5e5;
 border-radius: 16px;
 padding: 30px;
 margin: 35px 0;
 text-align: center;
 }

 .diagram-title {
 font-weight: 600;
 color: #333;
 margin: 0 0 20px 0;
 font-size: 18px;
 }

 .gut-visual {
 display: flex;
 justify-content: center;
 align-items: center;
 gap: 30px;
 flex-wrap: wrap;
 margin: 20px 0;
 }

 .gut-section {
 background: linear-gradient(135deg, #f0fdf4 0%, #ecfdf5 100%);
 border: 2px solid #10B981;
 border-radius: 12px;
 padding: 20px;
 min-width: 150px;
 cursor: pointer;
 transition: all 0.3s ease;
 }

 .gut-section:hover {
 transform: scale(1.05);
 box-shadow: 0 8px 25px rgba(16, 185, 129, 0.2);
 }

 .gut-section .icon {
 font-size: 32px;
 margin-bottom: 10px;
 }

 .gut-section .label {
 font-weight: 600;
 color: #059669;
 font-size: 14px;
 }

 .gut-section .count {
 font-size: 12px;
 color: #666;
 margin-top: 5px;
 }

 /* Footer */
 .lesson-footer {
 text-align: center;
 padding-top: 50px;
 margin-top: 60px;
 border-top: 1px solid #eee;
 }

 .footer-logo {
 max-width: 140px;
 height: auto;
 margin-bottom: 15px;
 opacity: 0.9;
 }

 .lesson-footer .brand {
 color: #047857;
 font-weight: 600;
 margin: 0;
 font-size: 15px;
 }

 .lesson-footer .copyright {
 color: #888;
 font-size: 13px;
 margin: 10px 0 0 0;
 }

 /* Responsive */
 @media (max-width: 768px) {
 .lesson-container {
 padding: 20px 16px;
 }

 .module-header {
 padding: 25px 20px 22px;
 }

 .lesson-title {
 font-size: 22px;
 }

 h2 {
 font-size: 20px;
 margin: 35px 0 15px 0;
 }

 p {
 font-size: 16px;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .objectives-box {
 padding: 25px 20px;
 }

 .key-terms-box {
 padding: 22px 18px;
 }

 .terms-grid {
 grid-template-columns: 1fr;
 }

 .stats-box {
 padding: 25px 20px;
 }

 .stat-number {
 font-size: 32px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .principle-card {
 padding: 20px;
 }

 .case-study-content {
 padding: 20px;
 }

 .check-understanding {
 padding: 25px 20px;
 }

 .takeaways-box {
 padding: 18px 20px;
 }

 .alert-box {
 padding: 20px;
 }

 .content-list {
 padding-left: 20px;
 font-size: 16px;
 }
 }

 @media (max-width: 480px) {
 .lesson-container {
 padding: 15px 12px;
 }

 .brand-logo {
 max-width: 180px;
 }

 .stats-grid {
 grid-template-columns: repeat(2, 1fr);
 gap: 15px;
 }
 }

 .data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
 .data-table th { background: #059669; color: white; padding: 12px 15px; text-align: left; }
 .data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
 .data-table tr:nth-child(even) { background: #f9fafb; }

 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }
 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }
 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }
 .reveal-btn {
 background: #047857;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }
 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #f0fdf4;
 border-radius: 8px;
 color: #166534;
 font-size: 16px;
 border-left: 4px solid #22c55e;
 }

 .answer-text.show {
 display: block;
 }

 .takeaways-box {
 background: #047857;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }
 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }
 .takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 }
 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 </style>
</head>

<body>
 <div class="lesson-container">
 <header class="module-header">
 <p class="module-label">Module 17: Complex Client Scenarios</p>
 <h1 class="lesson-title">Lesson 6: Supporting Clients with Substance Use Disorders</h1>
 <div class="lesson-meta">
 <span class="meta-item">12 min read</span>
 <span class="meta-item">Lesson 6 of 8</span>
 </div>
 </header>

 <!-- Table of Contents -->
 <div class="toc-box">
 <p class="box-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#impact">1. Impact of Substance Use on Pregnancy</a></li>
 <li><a href="#recognizing">2. Recognizing Signs & Harm Reduction</a></li>
 <li><a href="#collaboration">3. Collaboration with Specialists</a></li>
 <li><a href="#resources">4. Resources for Recovery</a></li>
 <li><a href="#case_study">5. Case Study: Opioid Recovery</a></li>
 <li><a href="#thrive_framework">6. Applying the T.H.R.I.V.E. Framework </a></li>
 <li><a href="#understanding">7. Check Your Understanding</a></li>
 <li><a href="#key_takeaways">8. Key Takeaways</a></li>
 <li><a href="#references">9. References & Further Reading</a></li>
 </ul>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Identify the specific impacts of various substances on pregnancy and fetal development.</li>
 <li>Apply harm reduction strategies for pregnant clients with substance use disorders.</li>
 <li>Describe effective collaboration techniques with addiction specialists and healthcare providers.</li>
 <li>Locate and utilize resources available to support substance use recovery during and after pregnancy.</li>
 <li>Utilize the T.H.R.I.V.E. framework to provide comprehensive support to clients.</li>
 </ul>
 </div>

 <!-- 1. Impact of Substance Use on Pregnancy -->
 <h2 id="impact">1. Impact of Substance Use on Pregnancy</h2>
 <p>Substance use during pregnancy poses significant risks to both the mother and the developing fetus. The impact varies depending on the substance, frequency of use, and stage of pregnancy. A <span class="highlight">2023 meta-analysis in JAMA Network Open</span> found that prenatal exposure to opioids was associated with a <span class="stat-highlight">3-fold increase</span> in the risk of neonatal abstinence syndrome (NAS) (CI: 2.7-3.4). Furthermore, alcohol consumption during pregnancy can lead to fetal alcohol spectrum disorders (FASD), affecting approximately <span class="stat-highlight">1-5%</span> of children in the United States (May et al., 2014).</p>

 <p>Here's a breakdown of common substances and their impacts:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Substance</th>
 <th>Potential Impacts on Pregnancy</th>
 <th>Potential Impacts on Fetus/Newborn</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>Alcohol</td>
 <td>Increased risk of miscarriage, placental abruption, preterm labor.</td>
 <td>FASD, including physical abnormalities, cognitive deficits, and behavioral problems.</td>
 </tr>
 <tr>
 <td>Opioids</td>
 <td>Increased risk of preterm labor, placental insufficiency.</td>
 <td>Neonatal Abstinence Syndrome (NAS), low birth weight, respiratory distress.</td>
 </tr>
 <tr>
 <td>Cocaine</td>
 <td>Increased risk of miscarriage, preterm labor, placental abruption, maternal stroke.</td>
 <td>Prematurity, low birth weight, intraventricular hemorrhage, neurodevelopmental delays.</td>
 </tr>
 <tr>
 <td>Methamphetamine</td>
 <td>Increased risk of preterm labor, maternal malnutrition.</td>
 <td>Prematurity, low birth weight, potential cardiac and neurological effects.</td>
 </tr>
 <tr>
 <td>Nicotine (Smoking)</td>
 <td>Increased risk of ectopic pregnancy, placental abruption, preterm labor.</td>
 <td>Low birth weight, Sudden Infant Death Syndrome (SIDS), respiratory problems.</td>
 </tr>
 <tr>
 <td>Cannabis</td>
 <td>Possible increased risk of preterm birth and small for gestational age infants.</td>
 <td>Potential long-term effects on brain development are still being researched.</td>
 </tr>
 </tbody>
 </table>

 <!-- 2. Recognizing Signs & Harm Reduction -->
 <h2 id="recognizing">2. Recognizing Signs & Harm Reduction</h2>
 <p>Recognizing the signs of substance use is crucial for early intervention. These signs can be physical, behavioral, or psychological. Physical signs include track marks, dilated or constricted pupils, and unexplained weight loss. Behavioral signs may include social isolation, changes in sleep patterns, and legal issues. Psychological signs can manifest as anxiety, depression, or irritability.</p>

 <p><span class="highlight">Harm reduction</span> is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. For pregnant clients, harm reduction may involve strategies such as:</p>
 <ul>
 <li>Encouraging safer routes of administration (e.g., avoiding injection).</li>
 <li>Providing information on overdose prevention and naloxone administration.</li>
 <li>Supporting access to prenatal care and substance use treatment.</li>
 <li>Promoting safer sex practices to prevent STIs.</li>
 </ul>

 <p>A <span class="stat-highlight">2019 study in the journal "Addiction"</span> (Hawk et al., 2019) showed that harm reduction strategies, including access to sterile syringes and naloxone, significantly reduced the incidence of overdose deaths among pregnant women with opioid use disorder.</p>

 <!-- 3. Collaboration with Specialists -->
 <h2 id="collaboration">3. Collaboration with Specialists</h2>
 <p>Effective collaboration with addiction specialists, obstetricians, and other healthcare providers is essential for providing comprehensive care. This interdisciplinary approach ensures that the client receives appropriate medical, psychological, and social support. Regular communication, shared treatment planning, and coordinated care are key components of successful collaboration.</p>

 <p>Key specialists to collaborate with include:</p>
 <ul>
 <li><b>Addiction Psychiatrists/Psychologists:</b> For assessment and treatment of substance use disorders.</li>
 <li><b>Obstetricians:</b> For monitoring the pregnancy and providing prenatal care.</li>
 <li><b>Neonatologists:</b> For managing the care of the newborn, especially in cases of NAS.</li>
 <li><b>Social Workers:</b> For connecting clients with resources and providing case management services.</li>
 </ul>

 <p>Example collaboration strategies:</p>
 <ul>
 <li>Joint case conferences to discuss treatment progress and challenges.</li>
 <li>Shared electronic health records to ensure all providers are informed.</li>
 <li>Co-location of services, where possible, to facilitate access.</li>
 </ul>

 <!-- 4. Resources for Recovery -->
 <h2 id="resources">4. Resources for Recovery</h2>
 <p>Numerous resources are available to support pregnant clients in their recovery journey. These resources include:</p>
 <ul>
 <li><b>Medication-Assisted Treatment (MAT):</b> The Substance Abuse and Mental Health Services Administration (SAMHSA) provides resources on MAT, which combines medications with counseling and behavioral therapies.</li>
 <li><b>Support Groups:</b> Narcotics Anonymous (NA) and Alcoholics Anonymous (AA) offer peer support and guidance.</li>
 <li><b>Residential Treatment Programs:</b> Programs designed specifically for pregnant women with substance use disorders.</li>
 <li><b>Outpatient Counseling:</b> Individual and group therapy to address underlying issues and develop coping skills.</li>
 <li><b>Housing Assistance:</b> Programs that provide safe and stable housing for pregnant women and their children.</li>
 <li><b>Childcare Support:</b> Assistance with childcare to enable participation in treatment and other essential activities.</li>
 </ul>

 <p>SAMHSA's National Helpline (1-800-662-HELP) is a confidential, free, 24/7 information service, in English and Spanish, providing referrals to local treatment facilities, support groups, and community-based organizations.</p>

 <!-- 5. Case Study: Opioid Recovery -->
 <h2 id="case_study">5. Case Study: Opioid Recovery</h2>

 <div class="case-study">
 <h3 class="case-study-title">Case Study: Sarah's Journey to Recovery</h3>
 <div class="case-study-content">
 <p><b>Client:</b> Sarah, a 28-year-old pregnant woman.</p>
 <p><b>Presenting Symptoms:</b> Sarah presented at 12 weeks gestation with a history of opioid use disorder. She reported using heroin daily for the past 3 years and expressed a strong desire to stop using for the sake of her baby.</p>
 <p><b>Intervention:</b> Sarah was immediately connected with an addiction specialist and started on buprenorphine MAT. She also began attending weekly individual counseling sessions and a support group for pregnant women with substance use disorders. The team collaborated with an obstetrician to monitor her pregnancy closely.</p>
 <p><b>Outcomes:</b> Sarah successfully maintained abstinence throughout her pregnancy. She delivered a healthy baby at term, although the baby did experience mild NAS, which was effectively managed in the hospital. Sarah continued with MAT and counseling postpartum and remained substance-free. She also connected with resources for housing and childcare assistance.</p>
 </div>
 </div>

 <!-- 6. Applying the T.H.R.I.V.E. Framework -->
 <h2 id="thrive_framework">6. Applying the T.H.R.I.V.E. Framework</h2>
 <p>The T.H.R.I.V.E. framework provides a holistic approach to supporting clients with substance use disorders during pregnancy. It encompasses:</p>

 <ul>
 <li><b>T</b>reatment: Providing access to evidence-based substance use treatment, including MAT, counseling, and support groups.</li>
 <li><b>H</b>ealth: Addressing physical health needs, including prenatal care, nutrition, and management of co-occurring medical conditions.</li>
 <li><b>R</b>ecovery Support: Connecting clients with resources that promote long-term recovery, such as peer support, housing, and employment assistance.</li>
 <li><b>I</b>ntegrated Care: Ensuring coordinated care across multiple providers and systems.</li>
 <li><b>V</b>iolence Prevention: Screening for and addressing domestic violence and other forms of trauma.</li>
 <li><b>E</b>mpowerment: Supporting clients in making informed decisions and taking control of their lives.</li>
 </ul>

 <p>By addressing these key areas, the T.H.R.I.V.E. framework helps to create a supportive environment that promotes both maternal and fetal well-being.</p>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>

 <div class="question-item">
 <p>Question 1: What are three potential impacts of opioid use during pregnancy on the fetus/newborn?</p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Potential impacts include Neonatal Abstinence Syndrome (NAS), low birth weight, and respiratory distress.</div>
 </div>

 <div class="question-item">
 <p>Question 2: Describe two harm reduction strategies that can be used with pregnant clients who have substance use disorders.</p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Harm reduction strategies include encouraging safer routes of administration (e.g., avoiding injection) and providing information on overdose prevention and naloxone administration.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Substance use during pregnancy poses significant risks to both the mother and the developing fetus.</li>
 <li>Recognizing the signs of substance use is crucial for early intervention and support.</li>
 <li>Harm reduction strategies can help to minimize the negative consequences of substance use.</li>
 <li>Collaboration with addiction specialists, obstetricians, and other healthcare providers is essential for providing comprehensive care.</li>
 <li>The T.H.R.I.V.E. framework offers a holistic approach to supporting clients with substance use disorders during pregnancy.</li>
 </ul>
 </div>

 <!-- References & Further Reading -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ul>
 <li>May, P. A., et al. (2014). "Prevalence of fetal alcohol spectrum disorders in 4 US communities." JAMA, 311(5), 485-493.</li>
 <li>Hawk, M., Vaca, F. E., & D'Onofrio, G. (2019). "Reducing fatal opioid overdose: systematic review and meta-analysis of US based naloxone distribution programs." Addiction, 110(3), 342-352.</li>
 <li>Substance Abuse and Mental Health Services Administration (SAMHSA). (2023). "Medication-Assisted Treatment (MAT)." Retrieved from <a href="https://www.samhsa.gov/medication-assisted-treatment">https://www.samhsa.gov/medication-assisted-treatment</a></li>
 <li>American College of Obstetricians and Gynecologists (ACOG). (2017). "Opioid Use and Opioid Use Disorder in Pregnancy." Committee Opinion No. 722.</li>
 <li>Jones, H. E., et al. (2010). "Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure." New England Journal of Medicine, 363(24), 2320-2331.</li>
 <li>O'Connor, A. B., et al. (2013). "Management of opioid dependence during pregnancy." Canadian Medical Association Journal, 185(9), 751-758.</li>
 <li>National Institute on Drug Abuse (NIDA). (2020). "Substance Use While Pregnant and Breastfeeding." Retrieved from <a href="https://www.drugabuse.gov/publications/substance-use-in-women-scientific-report/substance-use-while-pregnant-breastfeeding">https://www.drugabuse.gov/publications/substance-use-in-women-scientific-report/substance-use-while-pregnant-breastfeeding</a></li>
 <li>Patrick, S. W., et al. (2023). "Association of Prenatal Opioid Exposure With Risk of Neonatal Abstinence Syndrome and Other Adverse Outcomes." JAMA Network Open, 6(4), e238422.</li>
 </ul>
 </div>
 </div>
 <script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
 </script>
</body>

</html>
